NewGenIvf Group Limited (NASDAQ:NIVF) Stock Short Interest Report for October

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totaling 2,470,389 shares, an increase of 3,427.1% from the September 30th total of 70,041 shares. Based on an average daily volume of 33,175,029 shares, the days-to-cover ratio is presently 0.1 days. Currently, 325.1% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen cut shares of NewGenIvf Group to a “strong sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, the company presently has an average rating of “Sell”.

NewGenIvf Group Price Performance

Shares of NASDAQ:NIVF traded down $0.30 during trading on Monday, hitting $1.16. The company had a trading volume of 279,455 shares, compared to its average volume of 411,040. NewGenIvf Group has a one year low of $1.14 and a one year high of $21,425.47. The company has a fifty day simple moving average of $23.82 and a two-hundred day simple moving average of $463.22.

NewGenIvf Group (NASDAQ:NIVF) last issued its earnings results on Wednesday, October 7th. The company reported ($426.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $581.76 by ($1,008.00). The firm had revenue of $0.96 million for the quarter, compared to analysts’ expectations of $20.10 million. Equities analysts forecast that NewGenIvf Group will post 1365.44 EPS for the current year.

About NewGenIvf Group

NewGenIvf Group Limited is a reproductive-healthcare company focused on fertility treatment and assisted reproductive technology. Through its operating businesses, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF) and related fertility-care procedures.

Its services may include fertility consultations, laboratory-based embryo procedures, intracytoplasmic sperm injection (ICSI), embryo transfer, fertility preservation, and genetic testing or screening associated with assisted reproduction.